Phone: 08 8231 4169 | Email: info@hcasa.asn.au | Find HCASA on FacebookFollow HCASA on Twitter

Phone: 08 8231 4169
Email: info@hcasa.asn.au
Find HCASA on FacebookFollow HCASA on Twitter

hca logo

Consumers at the centre of health
in South Australia

The CHF Media release 30 November 2017 available here.

Health Consumer Councils across Australia, including HCA have released a joint media statement in response to the Therapeutic Goods Administration (TGA) action on mesh. As the state/territory peak health consumer organisations, we have added our voices to those of women across Australia, calling for the banning of mesh. You can read the full media release below.Health Consumer Councils across Australia have released a joint media statement in response to the Therapeutic Goods Administration (TGA) action on mesh. As the state/territory peak health consumer organisations we have added our voices to those of mesh-damaged women across Australia calling for the banning of mesh. We congratulate these women on the impact of their strong lobbying with the historic decision by the TGA to remove some mesh products (POP mesh and mini-slings) from their register of approved devices. This move has been celebrated by mesh-damaged women around the world. You can read the full media statement below.

Combined Australian State HCCs Mesh Release

A new regulatory framework for surgical mesh devices and provision of information to the consumers for all implantable medical devices has been approved by the Minister for Health, the Hon Greg Hunt. The changes are intended to maintain the alignment of the Australian regulatory framework with similar initiatives recently announced in Europe. They are another step in the implementation of the broader regulatory reform agenda set by the Review of the Medicines and Medical Devices Regulations. You can read more detail on the Therapeutic Goods Administration website here.

 

 

A story on ABC's Lateline at 9:30pm on Monday 14 August 2017 reveals that documents obtained by the ABC show the extent to which Johnson and Johnson oversold its surgical mesh products, which are used to treat incontinence and prolapse after childbirth. Find out more here.

HCA and our fellow health consumer organisations from across Australia launched a national campaign to understand the impact of pelvic mesh, tape or sling implants, which concluded Wednesday 31 May 2017. The Joint submission by Health Consumers Councils across Australia to the Senate Inquiry into the number of women in Australia who have had transvaginal mesh implants and related matters is now available below. All submissions made are available to view here.

 Joint submission by Health Consumers Councils across Australia 

The Australian Commission on Safety and Quality in Healthcare, following a request from state and territory health department representatives, is developing guidance for consumers, clinicians and health services on the use of transvaginal mesh products for the treatment of pelvic organ prolapse and stress urinary incontinence.

As part of this project, the Commission is reviewing the existing evidence on the use of transvaginal mesh and is working with a reference group that includes a range of clinical experts, consumer representatives and the Therapeutic Goods Administration. You can find out more by visiting their website here.

 

 

 

Subcategories

HCA on Facebook

HCA on Facebook

nothing about us without us